1-1 of 1
Tomoko Nanri, M.D.
Close
Sort by
Journal Articles

Imatinib Mesylate for Refractory Acute Myeloblastic Leukemia Harboring inv(16) and C-KIT Exon 8 Mutation.

Naofumi Matsuno, M.D., Tomoko Nanri, M.D., Toshiro Kawakita, M.D., Hiroaki Mitsuya, M.D., Norio Asou, M.D.
Journal: Blood
Blood (2004) 104 (11): 4405.
https://doi.org/10.1182/blood.V104.11.4405.4405
Published: 2004